Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines - PubMed (original) (raw)
. 1998 Sep 29;250(3):776-81.
doi: 10.1006/bbrc.1998.9394.
Affiliations
- PMID: 9784422
- DOI: 10.1006/bbrc.1998.9394
Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines
L C Hofbauer et al. Biochem Biophys Res Commun. 1998.
Abstract
Osteoprotegerin (OPG), a newly discovered member of the tumor necrosis factor receptor family, is a potent inhibitor of osteoclastogenesis. The overexpression of OPG in transgenic mice leads to osteopetrosis, whereas targeted ablation of OPG in knock-out mice leads to severe osteoporosis. However, the production and regulation of OPG in normal human bone has not been studied. Thus, we assessed OPG mRNA expression and protein secretion in human osteoblastic lineage cells. 1,25-Dihydroxyvitamin D3 (10(-7) M) increased OPG mRNA levels by 90 and 50% in a fetal osteoblastic cell line (hFOB) and normal trabecular osteoblastic cells (hOB) cells, respectively, but did not affect OPG mRNA levels in a marrow stromal preosteoblastic (hMS) cell line. Interleukin (IL)-1beta (5 x 10(-9) M), tumor necrosis factor (TNF)-alpha (9 x 10(-9) M), and bone morphogenetic protein (BMP)-2 (100 ng/ml) also increased OPG mRNA levels in hFOB cells by 4-, 6-, and 4-fold, respectively. Treatment with 1,25-dihydroxyvitamin D3, IL-1beta, TNF-alpha, and BMP-2 increased OPG protein production by hFOB cells by 60, 390, 300, and 80%, respectively (P < 0.001). Because it is expressed in various types of human osteoblastic cells, and is stimulated by vitamin D, BMP-2 and cytokines, OPG may be an important paracrine modulator of bone remodeling.
Copyright 1998 Academic Press.
Similar articles
- Regulation of osteoprotegerin secretion from primary cultures of human bone marrow stromal cells.
Brändström H, Björkman T, Ljunggren O. Brändström H, et al. Biochem Biophys Res Commun. 2001 Jan 26;280(3):831-5. doi: 10.1006/bbrc.2000.4223. Biochem Biophys Res Commun. 2001. PMID: 11162596 - Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts.
Viereck V, Emons G, Lauck V, Frosch KH, Blaschke S, Gründker C, Hofbauer LC. Viereck V, et al. Biochem Biophys Res Commun. 2002 Mar 1;291(3):680-6. doi: 10.1006/bbrc.2002.6510. Biochem Biophys Res Commun. 2002. PMID: 11855844 - Triiodothyronine (T3) and 1,25-dihydroxyvitamin D3 (1,25D3) inversely regulate OPG gene expression in dependence of the osteoblastic phenotype.
Varga F, Spitzer S, Klaushofer K. Varga F, et al. Calcif Tissue Int. 2004 Apr;74(4):382-7. doi: 10.1007/s00223-003-0033-5. Calcif Tissue Int. 2004. PMID: 15255076 - RANK-Fc: a therapeutic antagonist for RANK-L in myeloma.
Sordillo EM, Pearse RN. Sordillo EM, et al. Cancer. 2003 Feb 1;97(3 Suppl):802-12. doi: 10.1002/cncr.11134. Cancer. 2003. PMID: 12548579 Review. - The actions and interactions of sex steroids and growth factors/cytokines on the skeleton.
Spelsberg TC, Subramaniam M, Riggs BL, Khosla S. Spelsberg TC, et al. Mol Endocrinol. 1999 Jun;13(6):819-28. doi: 10.1210/mend.13.6.0299. Mol Endocrinol. 1999. PMID: 10379881 Review. No abstract available.
Cited by
- Convergence of Calcium Channel Regulation and Mechanotransduction in Skeletal Regenerative Biomaterial Design.
LaGuardia JS, Shariati K, Bedar M, Ren X, Moghadam S, Huang KX, Chen W, Kang Y, Yamaguchi DT, Lee JC. LaGuardia JS, et al. Adv Healthc Mater. 2023 Oct;12(27):e2301081. doi: 10.1002/adhm.202301081. Epub 2023 Jul 16. Adv Healthc Mater. 2023. PMID: 37380172 Free PMC article. Review. - An unbiased proteomics approach to identify the senescence-associated secretory phenotype of human bone marrow-derived mesenchymal stem cells.
Samsonraj RM, Law SF, Chandra A, Pignolo RJ. Samsonraj RM, et al. Bone Rep. 2023 Mar 21;18:101674. doi: 10.1016/j.bonr.2023.101674. eCollection 2023 Jun. Bone Rep. 2023. PMID: 36994454 Free PMC article. - Delineating the role of osteoprotegerin as a marker of breast cancer risk among women with a BRCA1 mutation.
Park SS, Uzelac A, Kotsopoulos J. Park SS, et al. Hered Cancer Clin Pract. 2022 Apr 13;20(1):14. doi: 10.1186/s13053-022-00223-3. Hered Cancer Clin Pract. 2022. PMID: 35418083 Free PMC article. Review. - Mineralizing Gelatin Microparticles as Cell Carrier and Drug Delivery System for siRNA for Bone Tissue Engineering.
Hinkelmann S, Springwald AH, Schulze S, Hempel U, Mitrach F, Wölk C, Hacker MC, Schulz-Siegmund M. Hinkelmann S, et al. Pharmaceutics. 2022 Feb 28;14(3):548. doi: 10.3390/pharmaceutics14030548. Pharmaceutics. 2022. PMID: 35335924 Free PMC article. - Femoral µCT Analysis, Mechanical Testing and Immunolocalization of Bone Proteins in β-Hydroxy β-Methylbutyrate (HMB) Supplemented Spiny Mouse in a Model of Pregnancy and Lactation-Associated Osteoporosis.
Tomaszewska E, Muszyński S, Donaldson J, Dobrowolski P, Chand DKP, Tomczyk-Warunek A, Hułas-Stasiak M, Puzio I, Lamorski K, Sławiński C, Jabłoński M, Blicharski T. Tomaszewska E, et al. J Clin Med. 2021 Oct 20;10(21):4808. doi: 10.3390/jcm10214808. J Clin Med. 2021. PMID: 34768327 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical